Pyxis Oncology, Inc. (PYXS)
Nasdaq: PYXS · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2019
Who owns Pyxis Oncology, Inc.
As filed with the SECHolders of 5% or more
5
GordonMD Global Investments LP holds 16.4% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed Oct 9, 2026 says.
Directors and officers
9
report now, of 17 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
GordonMD Global Investments LP
SCHEDULE 13G/A · filed Oct 9, 2026 · Common Stock, par value $0.001 per share · 17.5% in Oct 2, 2026
Lara Sullivan, M.D.
SCHEDULE 13D/A · filed Apr 2, 2025 · Common Stock, par value $0.001 per share · 10.3% in Dec 23, 2024
Bvf Partners L P/il
SCHEDULE 13G · filed Jul 10, 2026 · Common Stock, par value $0.001 per share
Laurion Capital Management LP
SCHEDULE 13G/A · filed Feb 9, 2026 · Common Stock, par value $0.001 per share
Coastlands Capital LP
SCHEDULE 13G · filed Oct 5, 2026 · Common Stock, par value $0.001 per share
Integrated Core Strategies (US) LLC
SCHEDULE 13G/A · filed May 6, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.3% in Dec 16, 2024
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 17, 2025 · Common Stock · reported falling below 5%, from 5.6% in Feb 4, 2025
Millennium Management LLC
SCHEDULE 13G/A · filed Oct 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.7% in Jul 1, 2025
Ridgeback Capital Investments L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
Deep Track Capital, LP
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
What PYXS reports owning in othersstakes of 5% or more, and other ties
3 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 21, 2024.
Insider tradesForm 4
1sales
0purchases
1sales on a scheduled plan
1people selling
$100,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 6, 2025 to Nov 6, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 6, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 29 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Dupont Jakob | director | 1 | $100,000 | 1 | 0 | $0 |
| Gordonmd Global Investments LP | 10% owner | 0 | $0 | 0 | 1 | $0 |